The Scripps Research Institute

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Jul 10, 2026

Suspended

A Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of CLF065 in the Treatment of Chronic Pouchitis

Jul 10, 2026

Completed

A Phase 1/1B Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Nebulized CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis

Earlier

Apr 17, 2025TrialA Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Jun 27, 2023TrialStudy to Assess PDM608 in Healthy Adult Subjects

Dec 1, 2021TrialMAP4343 Treatment for Alcohol Use Disorder

Nov 17, 2021TrialMedication Development in Alcoholism: Suvorexant Versus Placebo

Apr 15, 2021TrialMedication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo

Jul 17, 2020TrialFirst-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

2 more events

May 2, 2018TrialA Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis

Nov 1, 2017TrialMedication Development in Alcoholism: Apremilast Versus Placebo

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)